Lida A. Mina - Banner MD Anderson Cancer Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 106 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PS14-02: Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522

Mara Hofherr,Andrew Davis, Spenser January, Emily Owen,Farah Raheem,Lida A. Mina, Suganya Arunachalam Karikalan, Lauren Lyons, Meredith Watson Rose, Katherine Madden, Jerline Hsin, Aimee Keegan,

Cancer Researchno. 9_Supplement (2024): PS14-02

引用0浏览0引用

Patient-Reported Testing Burden of Screening Contrast-Enhanced Mammography

Bhavika K. Patel, Rachana Gurudu,Gina Mazza,Richard E. Sharpe,Lida Mina,Jessica Fraker,Juliana M. Kling, Karen Anderson,Danny Hughes,Barbara Pockaj

JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGYno. 5 (2024): 789-794

引用0浏览0WOS引用

Abstract PS14-06: Real-World Analysis of Adverse Events in Patients with Triple Negative Breast Cancer Receiving Therapy per KEYNOTE-522

Mara Hofherr,Katherine Clifton, Spenser January, Emily Owen, Farah Raheem,Lida A. Mina, Suganya Arunachalam Karikalan, Lauren Lyons, Meredith Watson Rose, Katherine Madden, Jerline Hsin, Aimee Keegan,

Cancer Researchno. 9_Supplement (2024): PS14-06

引用0浏览0引用

Factors influencing U.S. women’s interest and preferences for breast cancer risk communication: a cross-sectional study from a large tertiary care breast imaging center

Jessica D. Austin, Emily James, Rachel L Perez,Gina L. Mazza,Juliana M. Kling,Jessica Fraker,Lida Mina, Imon Banerjee, Richard Sharpe,Bhavika K. Patel

BMC Women's Healthno. 1 (2024): 1-10

引用0浏览0WOS引用

Abstract CT205: Neoadjuvant (Z)-endoxifen in premenopausal ER+, HER2- breast cancer: Evaluation of the first pharmacokinetic cohort of the EVANGELINE trial

Matthew P. Goetz, Vera J. Suman, Heather Fraser,Lida Mina, Pooja Advani,Roberto Leon-Ferre,Karthik Giridhar,Felipe Batalini,Katie N. Hunt, Swaathi Jayaraman,James Jakub, Patricia Cronin,

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis

Felipe Batalini, Laercio Lopes DaSilva,Leticia Campoverde, Ana Carolina Marin Comini, Bruno Murad Carvalho, Wilson Nogueira, Hyan Silveira,Brenda J. Ernst,Lida A. Mina

CHINESE CLINICAL ONCOLOGYno. 3 (2023): 21-21

引用0浏览0WOS引用

Supplementary Figure from Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline <i>BRCA1/2</i>-Mutated Breast Cancer